Hematology

Filter

New Therapeutic Targets Identified in Childhood Acute Myeloid Leukaemia

July 2025

A recent study has revealed promising targets for treating childhood acute myeloid leukaemia….

EHA 2025: CONCEPT Trial Shows Isatuximab Benefits High-Risk Myeloma

The Phase II CONCEPT trial has demonstrated that an isatuximab-based combination therapy achieves unprecedented rates of minimal residual disease negativity in patients with high-risk newly diagnosed multiple myeloma.

EHA 2025: Circulating Tumour Cells Offer Prognostic Insight in Multiple Myeloma

A large European analysis confirms circulating tumour cells (CTCs) as an independent prognostic biomarker in newly diagnosed multiple myeloma.

One-Third of Patients with Myeloma May Achieve Long-Term Survival

A new analysis of early total therapy clinical trials has revealed that up to one-third of patients with newly diagnosed multiple myeloma may achieve long-term survival.

Lower Transfusion Thresholds May Be Safe for Children Post-Transplant

A new UK clinical trial has found that children undergoing stem cell transplants may safely receive fewer blood transfusions.

Genomic Study Offers Breakthrough in Predicting Multiple Myeloma Progression

COMy 2025: Infection Risk High with Bispecific Antibodies in Myeloma

New research from COMy 2025 reveals a high rate of infections among people with relapsed or refractory multiple myeloma receiving bispecific antibodies…

COMy 2025: Senescence Biomarkers Predict Frailty and Survival in Myeloma

New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with frailty and overall survival in newly diagnosed multiple myeloma.

COMy 2025: CAR-T Cell Therapy Access Gaps in Myeloma

At COMy 2025, researchers highlighted barriers to EMA-approved CAR-T cell therapy access due to age, comorbidities, and inequality.

Loading posts...

« Previous 1 2 3 4 … 36 Next »